Cargando…
Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma
The PIM kinase family (PIM1, 2 and 3) play a central role in integrating growth and survival signals, and are expressed in a wide range of solid and hematological malignancies. We now confirm that PIM2 is overexpressed in multiple myeloma (MM) patients, and within MM group it is overexpressed in the...
Autores principales: | Nair, Jayakumar R., Caserta, Justin, Belko, Krista, Howell, Tyger, Fetterley, Gerald, Baldino, Carmen, Lee, Kelvin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537056/ https://www.ncbi.nlm.nih.gov/pubmed/28008178 http://dx.doi.org/10.1038/leu.2016.379 |
Ejemplares similares
-
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors
por: Katsuta, Eriko, et al.
Publicado: (2022) -
PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021) -
Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015) -
An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023) -
Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2022)